Wegovy reviews before and after: what real-world results look like

Step 1: the first four weeks, adjustment, not results

The starting dose of Wegovy is 0.25mg once weekly, and its job is straightforward: let your body get used to a GLP-1 receptor agonist before the dose climbs. Most people looking at one-month before and after accounts are surprised that the scales have barely moved at this stage. That is normal. Semaglutide reviews before and after the first four weeks almost universally describe the same pattern: reduced appetite beginning to appear, some nausea after the injection (usually on the day of, or the day after), and weight changes in the range of one to three kilograms at most. The therapeutic effect builds over weeks, not days. Some people find the injection easiest to do in the evening so any nausea passes during sleep, others keep their pen in the fridge door and do it straight after breakfast. Neither is wrong; what matters is the same day and same rough time each week, which is what the prescribing guidance recommends.

Step 2: weeks 4 to 20, the dose climbs, appetite falls

The standard escalation moves from 0.25mg to 0.5mg, then 1.0mg, then 1.7mg, with roughly four weeks at each level before the prescriber reviews whether to step up. By weeks 12 to 16 (when many people reach 1.7mg or the 2.4mg maintenance dose) appetite suppression is typically much more noticeable. This is when most UK users report the clearest before-and-after difference: smaller portions feeling satisfying, food noise quietening, and measurable weight loss appearing on the scales. The broader picture from Wegovy result reviews suggests the majority of weight loss in the STEP 1 trial was achieved during this escalation and early maintenance window. Side effects at each step-up are similar to week one: a few days of GI discomfort that typically settles. The NHS notes that nausea, diarrhoea, constipation and indigestion are the most common reactions, and that they are generally mild to moderate in intensity, the NHS semaglutide page lists full details and when to seek urgent help.

Step 3: maintenance and long-term before-and-after trajectories

At the 2.4mg maintenance dose, the STEP 1 data showed average losses of around 15% over 68 weeks. Individual wegovy before and after weight loss journeys reported in the UK sit across a wide band: some people reach 20% reduction, others find 8–10% is where their body stabilises. Neither is failure. Weight loss slows as the body adjusts, which is why the timeline for Wegovy to work is better measured in months than weeks. The MHRA approved a higher 7.2mg maintenance dose in January 2026, with trial data showing average losses of around 20.7% over 72 weeks, narrowing the gap with tirzepatide. That pen format is prescribed at clinical discretion; if you are already on Wegovy and wondering whether the higher dose is relevant for you, that is a conversation for your prescriber rather than something to self-select. For those considering starting, an overview of how Wegovy works covers the mechanism in more detail.

What before-and-after pictures and reviews can and cannot tell you

Before-and-after pictures circulating online (on social media especially) tend to show the most dramatic transformations. They are real, but they are also self-selected: people with striking visual results are far more likely to post than those with moderate ones. Semaglutide before and after reviews from UK users paint a more varied picture: sustained but gradual change, significant shifts in eating behaviour, and for many people, improvements in energy and mobility that matter as much as the number on the scales. A more grounded look at the range of Wegovy before and after outcomes helps set realistic expectations without dismissing how meaningful even modest weight loss can be for health markers like blood pressure and blood sugar. One thing reviews rarely mention: what happens to storage. Semaglutide pens need refrigeration, but there are questions about whether the rules change when travelling, what happens to semaglutide in the freezer is a practical question with a specific answer. For anyone thinking about starting, the clinical context matters: Wegovy is not a cosmetic treatment, and the MHRA is clear that GLP-1 medicines are not assessed or licensed for quick or aesthetic weight loss. A prescriber reviews whether the medicine is appropriate for your health picture, start your free consultation to have that conversation with a GPhC-registered prescriber at our UK pharmacy.